Evening Primrose Oil Efficacy in Second Trimester Abortion
NCT ID: NCT03698734
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
100 participants
INTERVENTIONAL
2018-11-01
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evening Primrose Oil to Misoprostol During Induction of Second-trimester Missed Miscarriage
NCT03584698
Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage
NCT03479879
Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage
NCT03628625
Management of Women With an Incomplete Miscarriage
NCT03148561
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
NCT03680339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Evening primrose oil
Evening primrose oil(EPO)
primiparous women with missed abortion between(13 to 24 weeks) will receive 1 capsule of EPO( 1000mg) in addition to misopristol
placebo
Placebo - Cap
primiparous women with missed abortion between(13 to 24 weeks) will receive 1 capsule of placebo in addition to misopristol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evening primrose oil(EPO)
primiparous women with missed abortion between(13 to 24 weeks) will receive 1 capsule of EPO( 1000mg) in addition to misopristol
Placebo - Cap
primiparous women with missed abortion between(13 to 24 weeks) will receive 1 capsule of placebo in addition to misopristol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Contraindications to medical or surgical uterine evacuations (eg, hemodynamically unstable, coagulopathy)
* Evidence of intra-uterine infection
* Rupture of fetal membranes.
* Intrauterine device in place.
* Allergy to prostaglandins or EPO
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Radwa Rasheedy Ali
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AinShams university maternity hospital
Cairo, Abbassya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed K Maklad, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASU obstetrics hosp
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.